FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

29910511000001105: Teragezza 2000microgram/35microgram tablets (Morningside Healthcare Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Aug 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
93262601000001117 Teragezza 2000microgram/35microgram tablets (Morningside Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
93262701000001110 Teragezza 2000microgram/35microgram tablets (Morningside Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Teragezza 2000microgram/35microgram tablets (Morningside Healthcare Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Teragezza 2000microgram/35microgram tablets (Morningside Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Teragezza 2000microgram/35microgram tablets (Morningside Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Teragezza 2000microgram/35microgram tablets (Morningside Healthcare Ltd) Is a Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Teragezza 2000microgram/35microgram tablets (Morningside Healthcare Ltd) Has active ingredient Ethinylestradiol false Inferred relationship Existential restriction modifier
Teragezza 2000microgram/35microgram tablets (Morningside Healthcare Ltd) Has active ingredient Cyproterone acetate false Inferred relationship Existential restriction modifier
Teragezza 2000microgram/35microgram tablets (Morningside Healthcare Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Teragezza 2000microgram/35microgram tablets (Morningside Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Teragezza 2000microgram/35microgram tablets (Morningside Healthcare Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Teragezza 2000microgram/35microgram tablets (Morningside Healthcare Ltd) Has specific active ingredient Ethinylestradiol true Inferred relationship Existential restriction modifier
Teragezza 2000microgram/35microgram tablets (Morningside Healthcare Ltd) Has specific active ingredient Cyproterone acetate true Inferred relationship Existential restriction modifier
Teragezza 2000microgram/35microgram tablets (Morningside Healthcare Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Teragezza 2000microgram/35microgram tablets (Morningside Healthcare Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Teragezza 2000microgram/35microgram tablets (Morningside Healthcare Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Teragezza 2000microgram/35microgram tablets (Morningside Healthcare Ltd) Is a Teragezza true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Teragezza 2000microgram/35microgram tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets Has AMP True Teragezza 2000microgram/35microgram tablets (Morningside Healthcare Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start